SALESFORCE LICENSES

销售人员许可证

• 批准号: 10721228
• 负责人: ELYSE SERAFIN
• 金额: $ 31.92万
• 依托单位: CARAHSOFT TECHNOLOGY CORPORATION
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-08-15 至 2023-08-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10721228
• 关键词: Goals; Government Agencies; Health; Heart Diseases; Hematological Disease; Individual; Industry; Institution; Leadership; Licensing; Lung diseases; National Heart, Lung, and Blood Institute; Prevention; Privatization; Research Infrastructure; Research Training; Services; System; Technology; Training and Education; cost; improved; programs

NHLBI / OM / ITAC continues to use Salesforce licenses (DOCS and NXP applications) to provide to the global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals. It creates and supports a robust, collaborative research infrastructure in partnership with private and public organizations, including academic institutions, industry, and other government agencies. The goal is to provide the NHLBI IOD and the OSPEEC correspondence management that engages and improves service to stakeholders and individuals more accurately and efficiently, reducing technology costs by utilizing a system built on Salesforce.

NHLBI / OM / ITAC继续使用Salesforce许可证（DOCS和恩智浦应用程序），为全球领导者提供研究、培训和教育计划，以促进心脏、肺和血液疾病的预防和治疗，并增强所有人的健康。它与私营和公共组织（包括学术机构、工业和其他政府机构）合作，创建并支持一个强大的协作研究基础设施。其目标是提供NHLBI IOD和OSPEEC通信管理，以便更准确、更有效地为利益相关者和个人提供服务，并通过利用基于Salesforce构建的系统降低技术成本。